NCT06049862

Brief Summary

This study aims to know the effectiveness of "MaRiTensi" in improving knowledge, motivation, efficacy, self-care and blood pressure control for hypertension patients. This study hypothesizes that MaRiTensi effectively increases the knowledge, motivation, self-efficacy and self-care of hypertensive patients and reduces blood pressure in the intervention group compared to the control group. Respondent recruitment is as follows:

  1. 1.The respondent candidate will be identified based on data on record medical
  2. 2.Appropriate respondent candidates' criteria inclusion and exclusion contacted for given informed consent
  3. 3.Prospective respondents who are willing to participate and fulfill the criteria for pressure blood moment measurement will request signed consent
  4. 4.Respondents fill in the basic data and recapitulate by the assistant researcher
  5. 5.Done randomization for allocation of group interventions and group control
  6. 6.Respondents given envelope closed (using sequentially numbered, opaque sealed envelopes (SNOSE) method )
  7. 7.Respondents' group intervention was given maintenance by Hospital or health center standard-added intervention using MaRiTensi by conditions; meanwhile, group control was provided care by Hospital or health center standards.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 22, 2023

Completed
19 days until next milestone

Study Start

First participant enrolled

October 11, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 28, 2024

Completed
Last Updated

July 9, 2024

Status Verified

July 1, 2024

Enrollment Period

7 months

First QC Date

September 11, 2023

Last Update Submit

July 8, 2024

Conditions

Keywords

HypertensionMobile HealthSelf-Management

Outcome Measures

Primary Outcomes (5)

  • The level of knowledge of hypertensive patients about hypertension

    Everything that hypertensive patients know about, definitions, medical drugs, drug adherence, lifestyle, diet, and complications as measured by 22 questions using the Indonesian version of the HK-LS questionnaire

    up to 12 weeks

  • The motivation of hypertensive patients

    The desire of hypertensive patients to take action to manage their hypertension as measured by 20 questions using the Indonesian version of the HBP-SCP questionnaire

    up to 12 weeks

  • Self-efficacy of hypertensive patients

    A hypertensive patient's belief that he can manage his hypertension well as measured by 20 questions using the Indonesian version of the HBP-SCP questionnaire

    up to 12 weeks

  • Self-care of hypertensive patients

    Actions initiated and performed by hypertensive patients to manage their disease as measured by 20 questions about self-management of hypertensive patients using the Indonesian version of the HBP-SCP questionnaire

    up to 12 weeks

  • Blood Pressure Control

    A condition in which hypertensive patients can control their blood pressure. The criterion that blood pressure is under control if it meets 1 of the following criteria: 1. There were no additional antihypertensive drugs during the study period 2. There were no additional doses of antihypertensive drugs during the study period 3. Blood pressure \<140 mmHg at the first and second evaluation

    up to 12 weeks

Study Arms (2)

MariTensi app and usual care

EXPERIMENTAL

Patients use the MaRitensi application to manage their hypertension by utilizing various menus in the application and continue receiving treatment as usual for 12 weeks.

Behavioral: MaRiTensi App

Usual care

NO INTERVENTION

The patient was not given the MaRitensi application and only received treatment as usual.

Interventions

MaRiTensi AppBEHAVIORAL

MaRiTensi is a mobile health-based hypertension self-management application used on Android smartphones. MariTensi provides facilities for recording blood pressure, BMI, activity, examination results, education about hypertension, consultations, reminders and community chat.

MariTensi app and usual care

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • A patient registered in the medical record of RSPR, the doctor diagnosed with hypertension based on ICD 10: I10; Age 18 to \<60 years; owning and being able to use a smartphone; living in Yogyakarta during the study period; blood pressure ≥ 140/90 mmHg measured at the time of visit.

You may not qualify if:

  • According to the doctor's diagnosis based on ICD 10:
  • Renal failure (ICD: N17-N19)
  • Diabetes Mellitus (ICD: E10-E14.9)
  • Stroke (ICD: I60-I69.8)
  • Acute Miocard Infarction (AMI) (ICD: I21-I21.9)
  • Heart Failure (ICD: I50-I50.9)
  • Cancer (ICD: C00-C97)
  • Dementia (ICD: F00-F04)
  • Mental disorders (ICD: F05-F99.9)
  • Thyroid Disease (ICD: E00-E07.9)
  • Human Immunodeficiency Virus (HIV) or Acquired Immunodeficiency Syndrome (AIDS) (ICD: B20)
  • Movement limitations: Hernia Nucleus Pulposus (HNP) (ICD: M50-M51.9); Piriformis Syndrome (ICD: G57-G57.9); Low Back Pain (LBP) (ICD: M54-M54.9); Frozen Shoulder (ICD: M75-75.9)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Puskesmas Depok 2

Sleman, D.I Yogyakarta, 55283, Indonesia

Location

Puskesmas Pakem

Sleman, DI Yogyakarta, 55582, Indonesia

Location

Panti Rapih Hospital

Yogyakarta, 55223, Indonesia

Location

Related Publications (1)

  • Widyastuti CS, Dinarti LK, Aulawi K, Lazuardi L. Effectiveness of mHealth on self-care profile and blood pressure among patients with hypertension in Indonesia: A single-blind randomized controlled trial. Belitung Nurs J. 2025 May 27;11(3):294-304. doi: 10.33546/bnj.3760. eCollection 2025.

MeSH Terms

Conditions

Essential HypertensionHypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Chatarina S Widyastuti

    Gadjah Mada University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
In the research, the third stage will do double-blinding for the care provider and outcome assessor, who will evaluate blood pressure and questionnaires. Allocation concealment for dividing into groups, intervention and control will use the SNOSE (sequentially numbered, opaque sealed envelopes ) method. The envelope closed will be sorted by order randomization, given paper carbon with appearance. The same is true for envelopes with the inscription intervention or control.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The intervention was given in the third phase of the research, namely "MaRiTensi," which was developed in the first and second stages of the research.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
S.Kep.,Ns.,M.Kep.,Sp.Kep.M.B

Study Record Dates

First Submitted

September 11, 2023

First Posted

September 22, 2023

Study Start

October 11, 2023

Primary Completion

April 28, 2024

Study Completion

April 28, 2024

Last Updated

July 9, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will share

Data share to other reseacher for data analysis because there is a mask in data analysis in this study

Shared Documents
SAP
Time Frame
during study period
Access Criteria
numeric data for data analysis

Locations